文献速递儿科影像心血管妇产影像US

抗Ro/SSA抗体暴露胎儿中不伴房室传导阻滞的心内膜弹力纤维增生症表现模式

Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

该多中心病例系列报告了11例抗Ro/SSA抗体暴露、首发表现为孤立性心内膜弹力纤维增生症(EFE)而不伴房室传导阻滞的胎儿,其中10例存在主动脉根/近端主动脉和/或左室流出道EFE及肺动脉根/肺动脉和/或右室流出道EFE,6例累及心房、6例累及心脏十字交叉;9例接受经胎盘地塞米松治疗(5例联合IVIG)、1例单用IVIG,10例治疗者中6例EFE改善、4例严重程度不变,全部活产,仅1例后续出现房室传导阻滞。

要点

  • 抗Ro/SSA抗体暴露胎儿可表现为不伴房室传导阻滞的孤立性EFE,主动脉和肺动脉根部及流出道受累几乎普遍存在。
  • 心房和心脏十字交叉受累也常见,提示阅片时需系统评估这些部位。
  • 本队列全部活产、房室传导阻滞负荷低,提示该表型预后良好。

核心结论

  • 在该队列中,主动脉和肺动脉及流出道EFE几乎普遍存在,心房和心脏十字交叉受累也常见;高存活率和低房室传导阻滞负荷提示这是抗Ro/SSA抗体介导心脏疾病的一种独特表型,预后良好。

研究设计与样本

  • 来自四个心脏中心的11例首发表现为孤立性EFE的胎儿,由有经验的胎儿心脏病专家就首发时超声心动图EFE位置达成共识,评估后续胎儿和出生后超声心动图的间隔变化以评价治疗反应。

关键影像表现/征象

  • 10例胎儿存在主动脉根、近端主动脉和/或左室流出道EFE。
  • 同一10例中识别出肺动脉根、肺动脉和/或右室流出道EFE。
  • 6例存在心房EFE,6例存在心脏十字交叉EFE。
  • 4例在诊断前已知抗Ro/SSA抗体阳性,其余7例因超声心动图发现而检测,均阳性。
  • 所有病例首发时房室间期正常,但1例胎儿后续出现房室传导阻滞。

临床应用与阅片要点

  • 9例接受经胎盘地塞米松治疗,其中5例同时接受静脉注射免疫球蛋白(IVIG),1例仅接受IVIG。
  • 10例治疗病例中,6例系列影像显示EFE改善,4例严重程度不变。
  • 所有患者均活产。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Anti-Ro/SSA-antibody-mediated endocardial fibroelastosis (EFE) without atrioventricular (AV) block at presentation is a rare cardiac phenotype. We report on 11 fetuses with this rare type of anti-Ro/SSA-antibody-mediated cardiac involvement, presenting with a distinctive echocardiographic pattern of EFE. Eleven fetuses with isolated EFE at presentation were included from four cardiac centers, and experienced fetal cardiologists reached a consensus regarding EFE location on echocardiography at presentation. Interval changes to subsequent fetal and postnatal echocardiograms were assessed to evaluate response to therapy. Echocardiographic markers of cardiac performance, including diastolic function and AV conduction, were reviewed. Ten fetuses were found to have EFE of the aortic root, proximal aorta and/or left ventricular outflow tract. In the same 10 cases, EFE of the pulmonary root, pulmonary artery and/or right ventricular outflow tract was identified. Six cases had atrial EFE and six had EFE of the crux. Four cases were known to be positive for anti-Ro/SSA antibodies prior to diagnosis, whereas, in the remaining seven, echocardiographic findings prompted testing, which was positive in all cases. The AV interval at presentation was normal in all cases, but one fetus subsequently developed AV block. Nine patients were treated with transplacental dexamethasone, five of which also received intravenous immunoglobulin (IVIG), and one received IVIG only. Of the 10 treated cases, six had improvement in EFE as shown by serial imaging and, in four cases, the severity was unchanged. All patients were liveborn. In our cohort, EFE of the aortic and pulmonary arteries and outflow tracts was nearly universal, and involvement of the atria and the crux of the heart was also common. The high survival rate and low burden of AV block are also suggestive of a distinct phenotype of anti-Ro/SSA-antibody-mediated cardiac disease with a favorable prognosis. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Keller SB, Cohen J, Moon-Grady A, et al. Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies. Ultrasound Obstet Gynecol. 2023. PMID: 36806323. doi:10.1002/uog.26181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。